United States · FDA National Drug Code directory
PIRFENIDONE
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 72205-181_2e84fe0d-424b-472b-938a-ef317ed61a79
- Product NDC
- 72205-181
- Form
- TABLET, FILM COATED
- Composition / generic term
- PIRFENIDONE
- Labeler
- Novadoz Pharmaceuticals LLC
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20220907
- Source listing expiry
- 20261231
Source-listed ingredients
- PIRFENIDONE — 267 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 3 BOTTLE in 1 CARTON (72205-181-26) / 90 TABLET, FILM COATED in 1 BOTTLE (72205-181-90) · 72205-181-26
- 3 BOTTLE in 1 CARTON (72205-181-36) / 30 TABLET, FILM COATED in 1 BOTTLE (72205-181-30) · 72205-181-36
- 9 BOTTLE in 1 CARTON (72205-181-38) / 30 TABLET, FILM COATED in 1 BOTTLE (72205-181-30) · 72205-181-38
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →